APP and Cognitive impairment: In this study, through taking advantage of transgenic APP/PS1 mice, a murine AD model, we show an ameliorating effect of miR-181a on cognitive deficits, which may relate to the retarded pericyte loss and blood-brain barrier breakdown via a negative regulation of pericyte apoptosis.